AMSTERDAM, May 20, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies, announced today that it is scheduled to present at the upcoming UBS Global Specialty and Generic Pharmaceuticals Conference in London, England on Wednesday, May 28, 2008. Gearoid Faherty, Chief Executive Officer of Eurand, will be presenting.
